Overview Safety, PK and PD of FLQ-101 in Premature Neonates Status: NOT_YET_RECRUITING Trial end date: 2026-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate safety and efficacy outcomes following exposure to FLQ-101.Phase: PHASE1 Details Lead Sponsor: FELIQS INC.